showing antiviral activity on A/H1N1 influenza virus. The presented agent (GA amide (1)) is 5 times less toxic for MDCK cells (CTD50 300 mcg/ml) than rimantadin, a known antiviral preparation (CTD50 60 mcg/ml), and possesses high antiviral activity; 50% effective concentration (EC50) of GA amide (1) is 0.2 mcg/ml, and in reference preparations: GA - 174 mcg/ml, rimantadin - 12 mcg/ml. GA amide (1) has a higher selectivity index (SI 1500) as compared to the reference preparations and 500 times as high as that of GA (SI 3.0) and 300 times as much as that of rimantadin (SI 5.0).;EFFECT: higher selectivity index of amide.;1 tbl, 3 ex"/>
公开/公告号RU2568849C9
专利类型
公开/公告日2016-03-20
原文格式PDF
申请/专利号RU20140144876
发明设计人 BALTINA LIDIJA ASHRAFOVNA;JUNUSOV MARAT SABIROVICH;BALTINA LIJA ALEKSANDROVNA;KISELEV OLEG IVANOVICH;ZARUBAEV VLADIMIR VIKTOROVICH;
申请日2014-11-06
分类号A61K31/7068;A61K31/506;A61P31/16;
国家 RU
入库时间 2022-08-21 14:10:57